[ad_1]
The US Food and Drug Administration (FDA) has approved the world's first drug that can treat cancer from its source and origin, in adults and children.
Vitrakvi depends on the treatment of genetic mutations of cancerous tumors, regardless of the type or location of the disease.
"The approval of the authorization and the introduction of this drug is an important step in the treatment of cancer because it treats it from its source and treats the basic genes of cancerous tumors independently from the location of their origin in the human body, "said Commissioner Scott Gottlieb.
Gottlieb has confirmed that this new drug will help cancer patients get proper treatment. Vitracave helps treat people with different cancers, but their genetic mutations are common.
"Traditionally, cancer was treated on the basis of cancerous growth, but now it will be anywhere in the body because it treats the gene originally responsible for the tumor," he said. said Dr. David Hayman, president of the Center for Early Drug Development at the New York-based Memorandum Sloan Kettering Cancer Center.
The drug has actually been tested on humans and a child was cured a few months after taking the drug, which will be administered to two bodies, one in tablet or capsule form and the other under form of children's medicine.
[ad_2]
Source link
